Clinical Trials

260 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06957691 2026-03-09

Fezo-ADT

60 enrolled

EndocrineGenitourinary

Adenocarcinoma, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT05672524 2026-03-04

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

37 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT04379596 2026-02-23

DG-03

450 enrolled

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT07259317 2026-02-20

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

60 enrolled

Adenocarcinoma, Carcinoma, Pancreatic Ductal

NCT06616597 2026-02-19

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

58 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT05620628 2026-01-21

Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

25 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT05208944 2026-01-20

THIO Sequenced With Cemiplimab in Advanced NSCLC

227 enrolled

Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT06846346 2025-11-28

GRACIE

88 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT06844383 2025-10-29

TALENT

126 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07179783 2025-09-18

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

28 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07018570 2025-08-26

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

26 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT04069273 2025-07-31

SEQUEL

58 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT06687876 2025-07-10

MEMENTO

14 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT07038304 2025-06-26

OLYMPIAN

35 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04543071 2025-06-19

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

10 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT05241249 2025-06-05

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

37 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT05776524 2025-03-25

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

46 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT05476796 2024-10-24

LOGICAN

118 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04974866 2023-03-29

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

20 enrolled

Adenocarcinoma, Carcinoma, Adenoid Cystic, Neoplasms, Glandular and Epithelial

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

78 enrolled